Product Information
PREGABALIN 25 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0428 per EA under NDC 69097067705. Its NADAC has been published 295 times since Nov 4, 2020.
Strength
25 mg/1
Manufacturer
Cipla USA Inc.NDC
69097067705
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212280On Market Since
1/10/2020
Price Statistics
The NADAC for PREGABALIN 25 MG CAPSULE has been published 295 times since Nov 4, 2020, and over the history we have for it it has declined 64.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0428 per EA |
|---|---|
| All-time high | $0.1195 (Nov 11, 2020) |
| All-time low | $0.0331 (Nov 20, 2024) |
| 52-week high | $0.0534 |
| 52-week low | $0.0428 |
| Median price | $0.0665 |
| Average price | $0.0677 |
| Largest weekly change | -46.0% (Nov 20, 2024) |
| Weeks tracked | 295 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PREGABALIN capsules, CV market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PREGABALIN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 25 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0428 per EA (NDC 69097067705), effective Jun 24, 2026.
How has the price of PREGABALIN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 25 MG CAPSULE has declined 64.2%. It has been tracked across 295 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for PREGABALIN 25 MG CAPSULE?
Since Nov 4, 2020, the NADAC for PREGABALIN 25 MG CAPSULE has ranged from a low of $0.0331 (Nov 20, 2024) to a high of $0.1195 (Nov 11, 2020), with a median of $0.0665 per EA.
Are there cheaper alternatives to PREGABALIN 25 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PREGABALIN 25 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN 25 MG CAPSULE?
PREGABALIN 25 MG CAPSULE (NDC 69097067705) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification